Safety and efficacy of apixaban, dabigatran and rivaroxaban in obese and morbidly obese patients with heart failure and atrial fibrillation: A real‐world analysis.

Autor: Chugh, Yashasvi1,2 yashasvichugh@gmail.com, Gupta, Kashvi3, Krishna, Hanumanthu Balram2, Ayala, Renato Quispe2, Zepeda, Ignacio2, Grushko, Michael2,4, Faillace, Robert T2
Zdroj: Pacing & Clinical Electrophysiology. Jan2023, Vol. 46 Issue 1, p50-58. 9p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje